| LOINC | LOINC INTERPRETATION |
| 50595-8 | Pathologist Interpretation of Specimen tests |
| 48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
| 31208-2 | Specimen Source |
| 67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
| 18718-7 | Cell marker studies (set); CDO Markers used |
| 33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
| 67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
| 69052-9 | Flow Cytometry specialist review of results |
| 55230-7 | Immunophenotyping study: Flow Cytometry report |
| 19139-5 | Pathologist name |
| Result Test ID | Reportable | Result Test Name | Result Type | Type (Alpha or Numeric) |
| FSR | N | SPECIMEN | I | A |
| FCHX | N | CLINICAL HISTORY | I | A |
| NUMSP | N | NUMBER OF SPECIMENS | I | A |
| FLOW2 | N | FLOW CYTOMETRY FOR LYMPHOMA/LEUKEMIA | I | A |
| LOINC | LOINC INTERPRETATION |
| 50595-8 | Pathologist Interpretation of Specimen tests |
| 48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
| 31208-2 | Specimen Source |
| 67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
| 18718-7 | Cell marker studies (set); CDO Markers used |
| 33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
| 67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
| 69052-9 | Flow Cytometry specialist review of results |
| 55230-7 | Immunophenotyping study: Flow Cytometry report |
| 19139-5 | Pathologist name |
| Specimen Requirements |
| Testing |
| Result Interpretation |
| Coding |
| LOINC | LOINC INTERPRETATION |
| 50595-8 | Pathologist Interpretation of Specimen tests |
| 48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
| 31208-2 | Specimen Source |
| 67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
| 18718-7 | Cell marker studies (set); CDO Markers used |
| 33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
| 67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
| 69052-9 | Flow Cytometry specialist review of results |
| 55230-7 | Immunophenotyping study: Flow Cytometry report |
| 19139-5 | Pathologist name |
| URM Labs Internal |
| Test Build |
| Result Test ID | Reportable | Result Test Name | Result Type | Type (Alpha or Numeric) |
| FSR | N | SPECIMEN | I | A |
| FCHX | N | CLINICAL HISTORY | I | A |
| NUMSP | N | NUMBER OF SPECIMENS | I | A |
| FLOW2 | N | FLOW CYTOMETRY FOR LYMPHOMA/LEUKEMIA | I | A |
| LOINC | LOINC INTERPRETATION |
| 50595-8 | Pathologist Interpretation of Specimen tests |
| 48767-8 | Annotation comment {Interpretation} Narrative: free text annotation comment that cam be appended to some other observation such as a lab result |
| 31208-2 | Specimen Source |
| 67127-1 | Cellularity assessment by Flow Cytometry: intended to express the distribution of cell types in a leukocyte population |
| 18718-7 | Cell marker studies (set); CDO Markers used |
| 33194-2 | Cell Viability: NYS and CAP requirement to perform viability testing |
| 67128-9 | Abnormal leukocytes/100 leukocytes in Specimen by Flow Cytometry: Hematopoietic malignancies can express on their surface particular subsets of cluster of differentiation (CD) antigens which deviate from the expression patterns of normal leukocytes |
| 69052-9 | Flow Cytometry specialist review of results |
| 55230-7 | Immunophenotyping study: Flow Cytometry report |
| 19139-5 | Pathologist name |
